The cancer therapy landscape is changing rapidly as CAR T cells achieve more regulatory approvals and gain traction in the clinic. The first approved CAR T-cell therapy, which treats acute lymphoblastic leukemia, is currently available in more than 130 treatment centers. As CAR T cells become more accessible to patients, the market is expected to grow: By 2030, one forecast predicts that the CAR T-cell market will reach a value of $6.1 billion.
Major players in the cell therapy market are Fibrocell Science Inc. , JCR Pharmaceuticals Co. Ltd.
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Bayers Parkinsons disease stem cell therapy has officially landed in the clinic while another treatment for the neurodegenerative movement disorder is seeking patients. The first dose of DA01, which the German Big Pharma refers to as pluripotent stem cell-derived dopaminergic neurons, was given out in a phase 1 test through its biotech subsidiary, BlueRock Therapeutics
Researchers at the University of Illinois Chicago have shown that even after lung tissue has been damaged, it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells. Pulmonary fibrosis is a chronic disease caused by environmental toxins, medications or medical conditions like pneumonia and rheumatoid arthritis.
Global Stem Cell Manufacturing Market: Overview Stem cells refer to special cells created by bone marrow of an individual. The key specialty of these cells is their ability to turn into various types of blood cells.
In the second part of our whats exciting the experts series, Medical News Today spoke with another group of cancer experts. We asked them what recent advances have given them the most hope
A team of researchers at the RIKEN Center for Biosystems Dynamics Research in Kobe, Japan, may have just found an answer to hair loss and baldness woes. While many methods have been devised in the past to address hair-related issues, this one is unique, for its a recipe for continuous cyclical regeneration of hair follicles from hair follicle stem cells. At RIKENs, a team led by Takashi Tsuji had been working on methods to regenerate lost hair from stem cells
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size, Status And Forecast 2021-2028 MarketInsightsReports, a leading global market research firm, is pleased to announce its new report on Hematopoietic Stem Cell Transplantation (HSCT) market, forecast for 2021-2028, covering all aspects of the market and providing up-to-date data on current trends. The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry.
June 4, 2021 John Theurer Cancer Center investigators report new findings at American Society of Clinical Oncology 2021 Annual Meeting Researchers from Hackensack University Medical Centers John Theurer Cancer Center, a part of Georgetown Lombardi Comprehensive Cancer Center, are presenting data from 25 studies at the Annual Meeting of the American Society of Clinical Oncology, the largest gathering of cancer professionals in the country. This years meeting is being held virtually June 4-8, 2021
Recent Comments